Page 12 - ATHM26_4
P. 12

(Z   + Z )  (σ  + σ )   (1.96 + 0.84)  (23.11 + 20.52)
                           2
                              2
                     α
                                                 2
                                   2
          n  = n  =   1- 2   1-β  1  2  =                      = 38
           1   2        (μ  - μ )               (5 - 2)
                              2
                                                     2
                         1   2
          were: (1) Death of the patient in the first 7 days; (2) Patients  Table 1. Mean and standard deviation of age in both
          undergoing brain surgery for treatment at the time of  silymarin and control groups
          referral; (3) Patient dissatisfaction; (4) Addicted patients;
          and, (5) Having severe trauma in other parts of the body.     Silymarin  Control
          Regarding the level of consciousness score and by comparing   Mean ±SD  Mean ±SD  P Value
          the formula of the average in the two groups with    Age  08/16± 37/33  00/16± 50/33  87/0
          99% confidence at least 38 subjects in each group and
          76 samples in total should be taken. The number of samples  No Significant Difference
          in each group is considered to be 40 individuals because of
          the drop, and the total numbers of samples were consequently  Table 2. Frequency of sex in two groups of silymarin and
          calculated as 80.                                  control

          RESULTS                                              Variable group   Number (%)
             As shown in Table 1, 2, 3, 4, 5 and 6, there was no a   Number (%)  Silymarin  Control  P Value
          significant difference between intervention group and control   Women  6(20)  7(5/17)  .5
          in terms of demographic parameters as age (P = .87), gender   Sex  Men  34(85)  33(5/82)
          (P = .5), residence of  participants (P = .30),  injury causes     Total  40(100)  40(100)
          (P =  .23), detailed analysis of injury causes (P = .18), and the
          incident site (P = .47). Both groups didn’t show significant  There was no significant difference between the two groups.
          difference as regards traumatic outcome as desirable
          traumatic outcome (P = 0.40), undesirable traumatic outcome  Table 3. Frequency of residence of participants in two
          (P  =  .12), consciousness level (P  =  .13), hospitalization  groups of silymarin and control
          duration (P = .82), and GOS (P = .19), (Table 7,8, 10, 11, 13).
          Regarding Table 9, there was a significant difference between           Number (%)
          the two groups (P = .002), where in the silymarin group there   Variable group  Silymarin  Control  P Value
          were more normal cases in terms of CT scan results. As       City    28(2/11)  31(4/12)  .30
          shown in Table 12, there was no significant difference   Residential   Village  12(8/4)  9(6/3)
          between the two groups regarding the incidence time of   location  Total  40(100)  40(100)
          accident to arrival at emergency unite (P = .06).
                                                             There was no significant difference between the two groups.
          DISCUSSION
             Silymarin is the active component of Silybum marianum L.,  Table 4. Frequency of injury causes in two groups of
          a member of Carduus marianum family containing a mixture  silymarin and control
          of flavonolignans consisting silibinin (Type A and B),
          isosilybinin (Type A and B), silycristin, silydianin,                     Number (%)
          neosilyhermin and silyhermin. 25                       Variable group  Silymarin  Control  P Value
             One of the important issues with silymarin is that it can be   Machine  24(6/9)  31(4/12)  .23
          safe as a proper herbal product, since no risks to health or side   Damage   Engine  8(2/3)  5(2)
          effects are associated with the suitable use of designed doses.   mechanism  Bullet fall  8(2/3)  4(6/1)
          Several studies have also been conducted on silymarin against   Total   40(100)  40(100)
          oxidation of stress and inflammatory responses. Silymarin has
          a  significant  antioxidant  effect,  which  reduces  free  radicals,  There was no significant difference between the two groups.
          inhibits lipid peroxidation and increases the activity of
          superoxide dismutase in erythrocytes. 26,27  Several studies have   reported for Silymarin, studies have been conducted to
          been conducted based upon the anti-oxidant properties of   investigate the effect of silymarin on wound healing, whereas
          Silymarin. Silymarin-treated diabetic groups have showed   most studies have been performed upon use of animal models.
          increased tissue levels of malondialdehyde, nitrite and nitrate   The objectives of the current study were different from
          in  diabetic  rats.  Four    weeks    treatment    of  Silymarin    Roghani et al. ; there was no significant association between
                                                                        28
          (100 mg/kg  bw) was determined to be associated with the   the two groups in our study, whereas the findings of CT scan
          reduction of  oxidative  stress  indexes in renal tissue of   were better after trauma in the Silymarin group.
          diabetic rats as previously reported by Roghani et al.    Another  study  had  evaluated  the  anti-inflammatory
                                                         28
          Considering the antioxidant and anti-inflammatory properties   effect of silymarin on the healing of acetic acid-induced


           10   ALTERNATIVE THERAPIES, JUL/AUG 2020 VOL. 26 NO. 4          Nazemi Rafi—Silymarine Effects on Prognosis of TBI
   7   8   9   10   11   12   13   14   15   16   17